Mandate

Vinge advises Transtema in connection with the acquisition of Ericsson Local Services

Transtema Group AB (publ), listed on Nasdaq First North, has entered into an agreement to acquire Ericsson Local Services AB (”LSS”), Ericsson’s field service business in Sweden.

LSS constructs and maintains network infrastructure, primarily in the southern and central parts of Sweden. During 2017, the business had a turnover of MSEK 1 162, at an adjusted EBITDA of MSEK 34. The purchase price amounts to a maximum of MSEK 180. The acquisition will be partly financed through a fully secured rights issue through subscription undertakings, letters of intent and warranty obligations from Transtema’s main owners. Closing is conditional upon the consent of the Swedish Competition Authority.

Vinge’s team primarily consisted of responsible partner Anders Strid together with Natalie Bäck (project manager M&A), Rebecka Maltenius (commercial property), Anna Backman (employment) as well as Anna Palmérus and Hugo Lundstedt (both competition law).
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025